SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001012477-19-000012
Filing Date
2019-11-12
Accepted
2019-11-12 15:59:46
Documents
93
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q avdl2019q3.htm 10-Q 2109398
2 EXHIBIT 31.1 exhibit311q32019.htm EX-31.1 10231
3 EXHIBIT 31.2 exhibit312q32019.htm EX-31.2 10126
4 EXHIBIT 32.1 exhibit321q32019.htm EX-32.1 5613
5 EXHIBIT 32.2 exhibit322q32019.htm EX-32.2 5622
  Complete submission text file 0001012477-19-000012.txt   9420426

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT avdl-20190930.xml EX-101.INS 2205297
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avdl-20190930.xsd EX-101.SCH 57572
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avdl-20190930_cal.xml EX-101.CAL 125910
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avdl-20190930_def.xml EX-101.DEF 248094
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avdl-20190930_lab.xml EX-101.LAB 731031
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avdl-20190930_pre.xml EX-101.PRE 439918
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37977 | Film No.: 191209151
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences